KIS counteracts PTBP2 and regulates alternative exon usage in neurons
eLife · 2024
DOI: 10.7554/elife.96048 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Marcos Moreno-Aguilera und 6 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Biology Institute of Barcelona (IBMB), CSIC, Barcelona, Spain. Hauptthemen laut MEDLINE: Alternative Splicing, Exons, Neurons, Polypyrimidine Tract-Binding Protein. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Ministerio de Ciencia e Innovación, Barts Charity.
Abstract (Originalsprache)
Alternative RNA splicing is an essential and dynamic process in neuronal differentiation and synapse maturation, and dysregulation of this process has been associated with neurodegenerative diseases. Recent studies have revealed the importance of RNA-binding proteins in the regulation of neuronal splicing programs. However, the molecular mechanisms involved in the control of these splicing regulators are still unclear. Here, we show that KIS, a kinase upregulated in the developmental brain, imposes a genome-wide alteration in exon usage during neuronal differentiation in mice. KIS contains a protein-recognition domain common to spliceosomal components and phosphorylates PTBP2, counteracting the role of this splicing factor in exon exclusion. At the molecular level, phosphorylation of unstructured domains within PTBP2 causes its dissociation from two co-regulators, Matrin3 and hnRNPM, and hinders the RNA-binding capability of the complex. Furthermore, KIS and PTBP2 display strong and opposing functional interactions in synaptic spine emergence and maturation. Taken together, our data uncover a post-translational control of splicing regulators that link transcriptional and alternative exon usage programs in neuronal development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Biology Institute of Barcelona (IBMB), CSIC, Barcelona, Spain.
- Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
ORCID-Profile: Marcos Moreno-Aguilera, Faraz K Mardakheh, Carme Gallego
Förderung
- Medical Research Council
- Ministerio de Ciencia e Innovación
- Barts Charity
Zitieren
APA
Moreno-Aguilera, M., Neher, A. M., Mendoza, M. B., Dodel, M., Mardakheh, F. K., Ortiz, R., & Gallego, C. (2024). KIS counteracts PTBP2 and regulates alternative exon usage in neurons. eLife. https://doi.org/10.7554/elife.96048
Vancouver
Moreno-Aguilera M, Neher AM, Mendoza MB, Dodel M, Mardakheh FK, Ortiz R, et al. KIS counteracts PTBP2 and regulates alternative exon usage in neurons. eLife. 2024. doi:10.7554/elife.96048
BibTeX
@article{MorenoAguilera2024,
author = {Moreno-Aguilera, Marcos and Neher, Alba M and Mendoza, Mónica B and Dodel, Martin and Mardakheh, Faraz K and Ortiz, Raúl and Gallego, Carme},
title = {KIS counteracts PTBP2 and regulates alternative exon usage in neurons},
journal = {eLife},
year = {2024},
doi = {10.7554/elife.96048}
}
EUVIMED